Global Vaccines Innovation and Immunology Conference (Hybrid Event) September 21-23, 2026 London, UK & Online (GVX 2026) provides a high-level platform for exploring cutting-edge vaccine science, emerging technologies, and global health challenges. This conference brings together a diverse audience of scientists, public health officials, pharmaceutical manufacturers, regulatory leaders, and innovation-driven start-ups to exchange knowledge on new vaccine platforms and the evolving landscape of immunization. The conference agenda is designed to address the most critical developments shaping global health security. Sessions include deep dives into mRNA updates, nanoparticle vaccine design, protein-subunit advancements, and vector-based platforms engineered for improved efficacy and safety. Vaccine Conference 2026 will also highlight the application of artificial intelligence, machine learning, and computational analytics in predicting immune responses, accelerating clinical trials, and optimizing vaccine manufacturing workflows. Participants will benefit from keynote lectures delivered by global leaders, interactive expert panels, scientific poster presentations, and hands-on workshops that cover laboratory techniques and digital tools. Immunology Congress will showcase innovations ranging from automated research platforms to temperature-stable formulations that address real-world challenges in low-resource settings. The hybrid model ensures that delegates worldwide can fully engage with the event. Virtual attendees can attend live sessions, participate in Q&A conversations, and connect with other professionals through interactive networking tools. In-person participants in London will gain access to exhibitions, collaboration hubs, and exclusive stakeholder meetings. Immunization Conferences is designed for professionals dedicated to advancing immunization programs, improving public health resilience, and accelerating the adoption of new technologies. The event fosters global partnerships and supports the scientific progress needed to prepare for future infectious disease threats.

Description supplied by the event organiser.